BR0315130A - Composições para terapia celular, terapeuticamente efetivas e de encapsulamento de material biológico, respectivos método e uso - Google Patents
Composições para terapia celular, terapeuticamente efetivas e de encapsulamento de material biológico, respectivos método e usoInfo
- Publication number
- BR0315130A BR0315130A BR0315130-1A BR0315130A BR0315130A BR 0315130 A BR0315130 A BR 0315130A BR 0315130 A BR0315130 A BR 0315130A BR 0315130 A BR0315130 A BR 0315130A
- Authority
- BR
- Brazil
- Prior art keywords
- biological materials
- biological
- materials
- encapsulated
- host
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0012—Cell encapsulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/74—Alginate
Abstract
"COMPOSIçõES PARA TERAPIA CELULAR, TERAPEUTICAMENTE EFETIVAS E DE ENCAPSULAMENTO DE MATERIAL BIOLóGICO, RESPECTIVOS MéTODOS E USO". A invenção presente se relaciona com composições para tratar uma doença, como diabete, implantando material encapsulado biológico num paciente carecido de tratamento. São apresentados vários métodos para revestimento de diversos tipos diferentes de materiais biológicos. As camadas podem ser diretamente colocadas sobre a superfície dos materiais biológicos ou sobre a superfície de outros materiais de revestimento que seguram os materiais biológicos. Os componentes das reações de polimerização que produzem as camadas podem incluir polímeros naturais e sintéticos, macrómeros, acceleradores, cocatalisadores, fotoiniciadores e radiação. Estes materiais biológicos encapsulados são usados para tratar uma variedade de diferentes doenças ou desordens humanas e animais implantando-os em várias áreas do corpo, inclusive em local subcutâneo. Os materiais de camada podern ser manipulados para prover diferentes graus de biocompatibilidade, características de difusividade de proteínas, resistência e biodegradabilidade para aperfeiçoar a liberação de materiais biológicos a partir do implante encapsulado até o recipiente hospedeiro, ao mesmo tempo que protegem os materiais biológicos encapsulados da destruição pelos mecanismos de inflamação e imuno do hospedeiro sem exigir tratamento antiinflamatório de longo prazo nem tratamento antiimuno do hospedeiro.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41901502P | 2002-10-11 | 2002-10-11 | |
PCT/US2003/032842 WO2004032881A2 (en) | 2002-10-11 | 2003-10-14 | Implantation of encapsulated biological materials for treating diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0315130A true BR0315130A (pt) | 2005-08-16 |
Family
ID=32094167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0315130-1A Pending BR0315130A (pt) | 2002-10-11 | 2003-10-14 | Composições para terapia celular, terapeuticamente efetivas e de encapsulamento de material biológico, respectivos método e uso |
Country Status (14)
Country | Link |
---|---|
US (2) | US7427415B2 (pt) |
EP (1) | EP1553893A4 (pt) |
JP (1) | JP2006503080A (pt) |
KR (1) | KR20050055760A (pt) |
CN (1) | CN1703175A (pt) |
AU (1) | AU2003285887B2 (pt) |
BR (1) | BR0315130A (pt) |
CA (1) | CA2501949A1 (pt) |
MX (1) | MXPA05003829A (pt) |
NZ (1) | NZ539713A (pt) |
PL (1) | PL376471A1 (pt) |
RU (1) | RU2340330C2 (pt) |
WO (1) | WO2004032881A2 (pt) |
ZA (1) | ZA200503534B (pt) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1301626A4 (en) * | 2000-05-08 | 2004-06-02 | Qtl Biosystems Llc | IMPROVEMENTS TO THE QTL-POLYMER FLUORESCENT BIODETECTION APPROACH |
US7440806B1 (en) * | 2000-11-21 | 2008-10-21 | Boston Scientific Neuromodulation Corp. | Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion |
US7493171B1 (en) * | 2000-11-21 | 2009-02-17 | Boston Scientific Neuromodulation Corp. | Treatment of pathologic craving and aversion syndromes and eating disorders by electrical brain stimulation and/or drug infusion |
US7608114B2 (en) | 2002-12-02 | 2009-10-27 | Gi Dynamics, Inc. | Bariatric sleeve |
US7122058B2 (en) | 2002-12-02 | 2006-10-17 | Gi Dynamics, Inc. | Anti-obesity devices |
US7025791B2 (en) | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
US7678068B2 (en) | 2002-12-02 | 2010-03-16 | Gi Dynamics, Inc. | Atraumatic delivery devices |
US7695446B2 (en) | 2002-12-02 | 2010-04-13 | Gi Dynamics, Inc. | Methods of treatment using a bariatric sleeve |
US7585499B2 (en) | 2003-04-10 | 2009-09-08 | Surmodics, Inc. | Method for encapsulation of cellular material using a charged initiator polymer |
US7820158B2 (en) * | 2003-04-10 | 2010-10-26 | Surmodics, Inc. | Ligand-coupled initiator polymers and methods of use |
US8202833B2 (en) * | 2003-11-26 | 2012-06-19 | Surmodics, Inc. | Composition containing biocompatible polymerization accelerator and polymerizable material |
US8057420B2 (en) | 2003-12-09 | 2011-11-15 | Gi Dynamics, Inc. | Gastrointestinal implant with drawstring |
WO2005060882A1 (en) | 2003-12-09 | 2005-07-07 | Gi Dynamics, Inc. | Apparatus to be anchored within the gastrointestinal tract and anchoring method |
US20050180957A1 (en) * | 2004-01-16 | 2005-08-18 | Scharp David W. | Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
DE602005027570D1 (de) | 2004-07-09 | 2011-06-01 | Gi Dynamics Inc | Vorrichtungen für die platzierung einer gastrotintestinalen hülse |
EP1799145B1 (en) | 2004-09-17 | 2016-12-21 | GI Dynamics, Inc. | Gastrointestinal anchor |
US7851189B2 (en) | 2005-03-07 | 2010-12-14 | Boston Scientific Scimed, Inc. | Microencapsulated compositions for endoluminal tissue engineering |
US7976488B2 (en) | 2005-06-08 | 2011-07-12 | Gi Dynamics, Inc. | Gastrointestinal anchor compliance |
WO2007002664A2 (en) * | 2005-06-22 | 2007-01-04 | Massachusetts Institute Of Technology | Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel |
WO2007047539A2 (en) * | 2005-10-14 | 2007-04-26 | Medtronic, Inc. | Localized delivery to the lymphatic system |
US20070098695A1 (en) * | 2005-10-31 | 2007-05-03 | Deolden James | Methods of islet separation during isolation |
CN101340887B (zh) | 2005-11-09 | 2014-01-29 | 科洛斯科技公司 | 使牙齿增白的组合物及方法 |
CA2634245C (en) * | 2005-12-28 | 2013-12-10 | Dentsply International Inc. | Light-curable bone growth material for treating dental bone defects |
BRPI0600473A (pt) * | 2006-02-06 | 2007-10-23 | Phb Ind Sa | implante polimérico e seu processo de preparação |
KR101505382B1 (ko) | 2006-03-07 | 2015-03-23 | 지타 쉬로프 | 인간 배아 줄기 세포 및 그의 유도체를 포함하는 조성물, 그의 사용 방법 및 제조 방법 |
US20090311328A1 (en) * | 2006-03-31 | 2009-12-17 | Csir | Bulking of Soft Tissue |
EP2015698B1 (en) | 2006-04-20 | 2017-11-15 | Sonendo, Inc. | Apparatus for treating root canals of teeth |
CN101522133B (zh) | 2006-08-08 | 2012-08-08 | 伊纳斯米特基金会 | 可植入的光学系统,其开发和应用的方法 |
US7980854B2 (en) | 2006-08-24 | 2011-07-19 | Medical Dental Advanced Technologies Group, L.L.C. | Dental and medical treatments and procedures |
US20100266989A1 (en) | 2006-11-09 | 2010-10-21 | Klox Technologies Inc. | Teeth whitening compositions and methods |
US8801647B2 (en) | 2007-02-22 | 2014-08-12 | Gi Dynamics, Inc. | Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks |
EA024725B1 (ru) | 2008-11-07 | 2016-10-31 | Клокс Текнолоджиз Инк. | Композиция для окислительного фотоактивируемого омоложения кожи, содержащая гиалуроновую кислоту, глюкозамин или аллантоин |
WO2010057039A2 (en) | 2008-11-14 | 2010-05-20 | Cythera, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
RU2011127144A (ru) * | 2008-12-02 | 2013-01-10 | Конинклейке Филипс Электроникс Н.В. | Соосно инкапсулированные клеточные суспензии и микроткани |
IL196820A0 (en) | 2009-02-01 | 2009-11-18 | Yissum Res Dev Co | Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells |
ES2849181T3 (es) | 2009-04-22 | 2021-08-16 | Viacyte Inc | Composiciones celulares derivadas de células reprogramadas desdiferenciadas |
US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
US20100318371A1 (en) * | 2009-06-11 | 2010-12-16 | Halliburton Energy Services, Inc. | Comprehensive hazard evaluation system and method for chemicals and products |
LT2453922T (lt) | 2009-07-17 | 2017-12-27 | Klox Technologies Inc. | Antibakterinė oralinė kompozicija |
US8709400B2 (en) * | 2009-07-27 | 2014-04-29 | Washington University | Inducement of organogenetic tolerance for pancreatic xenotransplant |
WO2011025977A2 (en) | 2009-08-28 | 2011-03-03 | Craig Hasilo | Methods and devices for cellular transplantation |
US8858990B2 (en) * | 2009-09-17 | 2014-10-14 | The Ohio State University | Capsule of thermogenic cells for treating a metabolic disease |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US9433557B2 (en) | 2011-02-21 | 2016-09-06 | Viacyte, Inc. | Loading system for an encapsulation device |
WO2012154627A2 (en) * | 2011-05-06 | 2012-11-15 | California Institute Of Technology | Light delivery device and related compositions, methods and systems |
US11116841B2 (en) | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
US20130281913A1 (en) | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
JP6231570B2 (ja) | 2012-09-14 | 2017-11-15 | ヴァレアント ファーマシューティカルズ インターナショナル インコーポレイテッドValeant Pharmaceuticals International, Inc. | 歯のホワイトニングのための組成物および方法 |
US20140276354A1 (en) | 2013-03-14 | 2014-09-18 | Klox Technologies Inc. | Biophotonic materials and uses thereof |
US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
US9950149B2 (en) | 2013-04-24 | 2018-04-24 | Nestec S.A. | Biomolecular cell encapsulation device and methods of implantation |
CN103305453A (zh) * | 2013-05-23 | 2013-09-18 | 侯亚义 | 一种脐带间充质干细胞的微载体培养系统 |
EP3013277B1 (en) | 2013-06-26 | 2023-07-19 | Sonendo, Inc. | Apparatus and methods for filling teeth and root canals |
EP3016686A4 (en) | 2013-07-03 | 2017-01-25 | Klox Technologies Inc. | Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds |
AU2015240385B2 (en) | 2014-04-01 | 2019-02-28 | Klox Technologies Inc. | Tissue filler compositions and methods of use |
US11051900B2 (en) | 2014-04-16 | 2021-07-06 | Viacyte, Inc. | Tools and instruments for use with implantable encapsulation devices |
US11229607B2 (en) * | 2014-06-30 | 2022-01-25 | President And Fellows Of Harvard College | Hydrogel compositions comprising encapsulated cells and methods of use thereof |
JP2017528572A (ja) * | 2014-09-15 | 2017-09-28 | クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. | 放射性高分子マトリクス |
ES2856841T3 (es) | 2014-10-31 | 2021-09-28 | Klox Tech Inc | Fibras y medios de tela fotoactivables |
CN104893825A (zh) * | 2015-06-11 | 2015-09-09 | 东华大学 | 一种以聚脲为囊壁的香精微胶囊及其制备方法 |
US10918673B2 (en) | 2015-08-28 | 2021-02-16 | The Regents Of The University Of Michigan | Immunoisolation device |
US10576042B2 (en) | 2015-11-23 | 2020-03-03 | Association For The Advancement Of Tissue Engineering Cell Based Technologies & Therapies Associaçao | Composition comprising polyelectrolyte complexes, methods and uses thereof |
US20170252304A1 (en) * | 2016-03-01 | 2017-09-07 | Prodo Laboratories, Inc. | Encapsulation Methods and Compositions |
EP3426263A4 (en) * | 2016-03-09 | 2019-10-16 | Incube Labs, LLC | METHOD AND ARTICLE FOR THE DELIVERY OF LIVABLE CELLS IN SOLID TISSUE |
US11655343B2 (en) | 2016-03-24 | 2023-05-23 | Takeda Pharmaceutical Company Limited | Alginate hydrogel compositions |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US20180035924A1 (en) * | 2016-08-02 | 2018-02-08 | Medtronic, Inc. | Accelerometer signal change as a measure of patient functional status |
US11052230B2 (en) | 2016-11-08 | 2021-07-06 | W. L. Gore & Associates, Inc. | Implantable encapsulation devices |
RU2019114817A (ru) * | 2016-11-15 | 2020-11-16 | Джинер Лайф Сайенс, Инк. | Устройство чрезкожной диффузии газов, подходящее для применения с подкожным имплантатом |
EP3554569A1 (en) * | 2016-12-13 | 2019-10-23 | Millennium Pharmaceuticals, Inc. | Conformal coating of biological surfaces |
CN110709137A (zh) * | 2017-04-06 | 2020-01-17 | 塞拉克西斯股份有限公司 | 大胶囊化的治疗性细胞及其使用方法 |
WO2019152767A1 (en) * | 2018-02-02 | 2019-08-08 | Wake Forest University Health Sciences | Organoids related to immunotherapy and methods of preparing and using the same |
CN113727742A (zh) * | 2019-03-29 | 2021-11-30 | 南洋理工大学 | 治疗性水凝胶装置 |
WO2020223706A1 (en) * | 2019-05-02 | 2020-11-05 | Sonendo, Inc. | Hydrogel materials for obturation |
CN110251731B (zh) * | 2019-06-26 | 2021-09-03 | 山东百多安医疗器械股份有限公司 | 一种组织工程用胰岛细胞微囊及其制备方法 |
CN110201234B (zh) * | 2019-06-26 | 2021-09-03 | 山东百多安医疗器械股份有限公司 | 一种组织工程用前列腺细胞微囊及其制备方法 |
FR3108260B1 (fr) * | 2020-03-17 | 2024-01-05 | Neurobiomat | Hydrogel hétérogène hybride, procédé de fabrication et utilisation comme implant de comblement non-dégradable in-situ |
USD997355S1 (en) | 2020-10-07 | 2023-08-29 | Sonendo, Inc. | Dental treatment instrument |
US20240041755A1 (en) * | 2020-12-22 | 2024-02-08 | William Marsh Rice University | Implantable constructs for modulating an immune response |
CN114949369B (zh) * | 2021-02-19 | 2023-09-05 | 清华大学 | 一种人工组织器官的封装装置及其制备方法和应用 |
WO2023164171A2 (en) | 2022-02-25 | 2023-08-31 | Viacyte, Inc. | Multilayer implantable cell encapsulation devices and methods thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5168053A (en) | 1989-03-24 | 1992-12-01 | Yale University | Cleavage of targeted RNA by RNAase P |
US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5380536A (en) | 1990-10-15 | 1995-01-10 | The Board Of Regents, The University Of Texas System | Biocompatible microcapsules |
US5232984A (en) | 1990-10-15 | 1993-08-03 | The Board Of The Regents The University Of Texas | Biocompatible microcapsules |
US20030087985A1 (en) | 1990-10-15 | 2003-05-08 | Hubbell Jeffrey A. | Gels for encapsulation of biological materials |
US5462990A (en) | 1990-10-15 | 1995-10-31 | Board Of Regents, The University Of Texas System | Multifunctional organic polymers |
US5529914A (en) | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
US5626863A (en) | 1992-02-28 | 1997-05-06 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
AU3124793A (en) | 1991-10-29 | 1993-06-07 | Clover Consolidated, Limited | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
US5545423A (en) | 1991-11-25 | 1996-08-13 | Vivorx, Inc. | Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
US5573934A (en) | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
ATE197125T1 (de) | 1992-02-28 | 2000-11-15 | Univ Texas | Photopolymerinierbare, biologisch abbaubare hydrogele als gewebekontaktmaterialien und trägerstoffe für kontrollierte freisetzung |
US5578442A (en) * | 1992-03-23 | 1996-11-26 | Vivorx, Inc. | Graft copolymers of polycationic species and water-soluble polymers, and use therefor |
US5334640A (en) | 1992-04-08 | 1994-08-02 | Clover Consolidated, Ltd. | Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods |
WO1996029370A2 (en) | 1995-03-23 | 1996-09-26 | Focal, Inc. | Redox and photoinitiator systems for priming for improved adherence of gels to substrates |
US6565842B1 (en) | 1995-06-07 | 2003-05-20 | American Bioscience, Inc. | Crosslinkable polypeptide compositions |
US5714360A (en) | 1995-11-03 | 1998-02-03 | Bsi Corporation | Photoactivatable water soluble cross-linking agents containing an onium group |
JP4803853B2 (ja) | 1996-09-23 | 2011-10-26 | ジェンザイム・コーポレーション | カーボネートまたはジオキサノン結合を含む重合可能な生体分解性のポリマー |
US6368612B1 (en) * | 1997-12-12 | 2002-04-09 | Biohybrid Technologies Llc | Devices for cloaking transplanted cells |
US6410044B1 (en) | 1998-03-19 | 2002-06-25 | Surmodics, Inc. | Crosslinkable macromers |
US6007833A (en) | 1998-03-19 | 1999-12-28 | Surmodics, Inc. | Crosslinkable macromers bearing initiator groups |
US6326201B1 (en) | 1999-02-10 | 2001-12-04 | Curis, Inc. | Pancreatic progenitor cells, methods and uses related thereto |
US6495161B1 (en) | 1999-03-09 | 2002-12-17 | Vivorx, Inc. | Cytoprotective biocompatible containment systems for biologically active materials and methods of making same |
US6278018B1 (en) | 1999-12-14 | 2001-08-21 | Surmodics, Inc. | Surface coating agents |
FR2814752A1 (fr) | 2000-10-02 | 2002-04-05 | Chru Lille | Procede d'obtention in vitro de cellules insulino- secretrices de mammifere et leurs utilisations |
-
2003
- 2003-10-14 EP EP03779114A patent/EP1553893A4/en not_active Withdrawn
- 2003-10-14 CA CA002501949A patent/CA2501949A1/en not_active Abandoned
- 2003-10-14 AU AU2003285887A patent/AU2003285887B2/en not_active Ceased
- 2003-10-14 JP JP2004543792A patent/JP2006503080A/ja active Pending
- 2003-10-14 PL PL03376471A patent/PL376471A1/xx not_active Application Discontinuation
- 2003-10-14 CN CNA200380101267XA patent/CN1703175A/zh active Pending
- 2003-10-14 NZ NZ539713A patent/NZ539713A/en not_active IP Right Cessation
- 2003-10-14 RU RU2005113684/15A patent/RU2340330C2/ru not_active IP Right Cessation
- 2003-10-14 KR KR1020057006208A patent/KR20050055760A/ko not_active Application Discontinuation
- 2003-10-14 MX MXPA05003829A patent/MXPA05003829A/es active IP Right Grant
- 2003-10-14 BR BR0315130-1A patent/BR0315130A/pt active Pending
- 2003-10-14 WO PCT/US2003/032842 patent/WO2004032881A2/en active Application Filing
- 2003-10-14 US US10/684,859 patent/US7427415B2/en not_active Expired - Fee Related
-
2005
- 2005-05-04 ZA ZA200503534A patent/ZA200503534B/en unknown
-
2008
- 2008-08-22 US US12/197,040 patent/US20090004238A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040136971A1 (en) | 2004-07-15 |
RU2005113684A (ru) | 2006-01-20 |
PL376471A1 (en) | 2005-12-27 |
AU2003285887B2 (en) | 2008-09-11 |
WO2004032881A3 (en) | 2004-09-02 |
EP1553893A4 (en) | 2010-09-22 |
MXPA05003829A (es) | 2005-10-05 |
CN1703175A (zh) | 2005-11-30 |
WO2004032881A2 (en) | 2004-04-22 |
CA2501949A1 (en) | 2004-04-22 |
US7427415B2 (en) | 2008-09-23 |
AU2003285887A1 (en) | 2004-05-04 |
NZ539713A (en) | 2008-07-31 |
US20090004238A1 (en) | 2009-01-01 |
EP1553893A2 (en) | 2005-07-20 |
ZA200503534B (en) | 2006-08-30 |
KR20050055760A (ko) | 2005-06-13 |
JP2006503080A (ja) | 2006-01-26 |
RU2340330C2 (ru) | 2008-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0315130A (pt) | Composições para terapia celular, terapeuticamente efetivas e de encapsulamento de material biológico, respectivos método e uso | |
BR9715022A (pt) | Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada | |
Goldin et al. | The effects of Diapulse on the healing of wounds: a double-blind randomised controlled trial in man | |
ATE339227T1 (de) | Beschichtetes medizinsches implantat zur behandlung von gefässerkrankungen | |
ATE358505T1 (de) | Beschichtete endovaskuläre vorrichtung | |
ATE496643T1 (de) | Verwendung von antioxidantien zur verhinderung von oxidation und zur reduzierung von wirkstoffzersetzung in wirkstoffhaltigen medizinischen artikeln | |
BRPI0414455A (pt) | métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins | |
ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
BR9712599A (pt) | Processos para o tratamento de um volume particular, de câncer e de um volume de tecido canceroso em tecido e para produzir pelo menos um agente molecular foto-ativo num volume particular de material e aparelhos para o tratamento de um volume particular de tecido de planta ou de animal e para a administração de um tratamento médico foto-dinâmico | |
BR9807916A (pt) | Conjunto de dispositivo biomédico, método para inibir substancialmente a reestenose em um vaso sanguìneo de um paciente, método para fabricar um conjunto de dispositivo biomédico. | |
KR900700073A (ko) | 결합 유도 조성물 | |
CN1145031A (zh) | 用于皮肤和毛发的淀粉-金属配合物 | |
ATE302029T1 (de) | Beschichtete medizinische geräte und verfahren zur sterilisation | |
Perkins et al. | Current materials and techniques used in a burn scar management programme | |
CN1228145C (zh) | 用高效材料涂布物件的装置、方法及其应用和成品 | |
DK0821969T3 (da) | Medicinsk sammensætning omfattende TCF-II | |
JP2004525666A5 (pt) | ||
US4370136A (en) | Treatment for periodontal diseases | |
DE60202446D1 (de) | Pharmazeutische formulierung und ihre verwendung für die herstellung eines medikaments zur behandlung von herz-kreislauf-erkrankungen | |
CN1135108C (zh) | 一种治疗关节及软组织损伤的药物 | |
CN2170102Y (zh) | 药物涤纶人工皮 | |
CN1086125C (zh) | 一种治疗癣病的外用药 | |
CN1236798C (zh) | 一种治疗骨结核的外敷药物 | |
CN2696662Y (zh) | 一种术后切口敷贴 | |
SU1491507A1 (ru) | Способ подготовки к протезированию больных с культ ми нижних конечностей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES. |
|
B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2256 DE 01/04/2014 POR TER SIDO INDEVIDA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A, 16A E 17A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |